nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—bone cancer—Paget's disease of bone	0.448	0.587	CtDrD
Doxorubicin—sarcoma—Paget's disease of bone	0.316	0.413	CtDrD
Doxorubicin—ABCC1—Zoledronate—Paget's disease of bone	0.0719	1	CbGbCtD
Doxorubicin—CBR3—NRF2 pathway—SQSTM1—Paget's disease of bone	0.00155	0.0596	CbGpPWpGaD
Doxorubicin—NOS1—Monoamine Transport—TNFRSF11B—Paget's disease of bone	0.00152	0.0584	CbGpPWpGaD
Doxorubicin—YWHAG—IL3-mediated signaling events—INPP5D—Paget's disease of bone	0.0011	0.0424	CbGpPWpGaD
Doxorubicin—NDUFS2—p73 transcription factor network—PML—Paget's disease of bone	0.00102	0.0392	CbGpPWpGaD
Doxorubicin—AURKA—Regulation of PLK1 Activity at G2/M Transition—OPTN—Paget's disease of bone	0.00102	0.0391	CbGpPWpGaD
Doxorubicin—YWHAG—Regulation of PLK1 Activity at G2/M Transition—OPTN—Paget's disease of bone	0.00077	0.0296	CbGpPWpGaD
Doxorubicin—AURKA—G2/M Transition—OPTN—Paget's disease of bone	0.000763	0.0294	CbGpPWpGaD
Doxorubicin—AURKA—Mitotic G2-G2/M phases—OPTN—Paget's disease of bone	0.000752	0.029	CbGpPWpGaD
Doxorubicin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—BGLAP—Paget's disease of bone	0.000709	0.0273	CbGpPWpGaD
Doxorubicin—NOS3—Endothelin Pathways—CALCA—Paget's disease of bone	0.000648	0.025	CbGpPWpGaD
Doxorubicin—NQO1—Validated transcriptional targets of TAp63 isoforms—PML—Paget's disease of bone	0.000639	0.0246	CbGpPWpGaD
Doxorubicin—NOS2—AGE/RAGE pathway—ALPL—Paget's disease of bone	0.00062	0.0239	CbGpPWpGaD
Doxorubicin—NOS2—Circadian rythm related genes—TNFRSF11A—Paget's disease of bone	0.000604	0.0233	CbGpPWpGaD
Doxorubicin—YWHAG—G2/M Transition—OPTN—Paget's disease of bone	0.000578	0.0223	CbGpPWpGaD
Doxorubicin—YWHAG—Mitotic G2-G2/M phases—OPTN—Paget's disease of bone	0.00057	0.022	CbGpPWpGaD
Doxorubicin—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—SQSTM1—Paget's disease of bone	0.000561	0.0216	CbGpPWpGaD
Doxorubicin—YWHAG—mTOR signaling pathway—PML—Paget's disease of bone	0.000558	0.0215	CbGpPWpGaD
Doxorubicin—SLC22A16—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	0.000508	0.0196	CbGpPWpGaD
Doxorubicin—NOS3—AGE/RAGE pathway—ALPL—Paget's disease of bone	0.000482	0.0186	CbGpPWpGaD
Doxorubicin—RALBP1—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.000445	0.0172	CbGpPWpGaD
Doxorubicin—CBR1—NRF2 pathway—SQSTM1—Paget's disease of bone	0.000427	0.0164	CbGpPWpGaD
Doxorubicin—ABCB8—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000418	0.0161	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—TNFRSF11A—Paget's disease of bone	0.000413	0.0159	CbGpPWpGaD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—PML—Paget's disease of bone	0.00038	0.0146	CbGpPWpGaD
Doxorubicin—AURKA—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.000346	0.0133	CbGpPWpGaD
Doxorubicin—NOS1—Myometrial Relaxation and Contraction Pathways—CALCA—Paget's disease of bone	0.000321	0.0124	CbGpPWpGaD
Doxorubicin—SLC22A16—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000258	0.00994	CbGpPWpGaD
Doxorubicin—NQO1—NRF2 pathway—SQSTM1—Paget's disease of bone	0.000249	0.0096	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle, Mitotic—OPTN—Paget's disease of bone	0.000243	0.00934	CbGpPWpGaD
Doxorubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—CALCA—Paget's disease of bone	0.000237	0.00912	CbGpPWpGaD
Doxorubicin—NOS2—Circadian rythm related genes—PML—Paget's disease of bone	0.000234	0.00902	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—OPTN—Paget's disease of bone	0.000217	0.00835	CbGpPWpGaD
Doxorubicin—NOS3—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.000209	0.00803	CbGpPWpGaD
Doxorubicin—Malaise—Alendronate—Paget's disease of bone	0.0002	0.00144	CcSEcCtD
Doxorubicin—Vertigo—Alendronate—Paget's disease of bone	0.000199	0.00144	CcSEcCtD
Doxorubicin—Infestation—Zoledronate—Paget's disease of bone	0.000198	0.00143	CcSEcCtD
Doxorubicin—Infestation NOS—Zoledronate—Paget's disease of bone	0.000198	0.00143	CcSEcCtD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000196	0.00753	CbGpPWpGaD
Doxorubicin—Haemoglobin—Pamidronate—Paget's disease of bone	0.000195	0.00141	CcSEcCtD
Doxorubicin—Rhinitis—Pamidronate—Paget's disease of bone	0.000195	0.00141	CcSEcCtD
Doxorubicin—Renal failure—Zoledronate—Paget's disease of bone	0.000194	0.0014	CcSEcCtD
Doxorubicin—Haemorrhage—Pamidronate—Paget's disease of bone	0.000194	0.0014	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.000193	0.0014	CcSEcCtD
Doxorubicin—Stomatitis—Zoledronate—Paget's disease of bone	0.000193	0.00139	CcSEcCtD
Doxorubicin—Urinary tract infection—Zoledronate—Paget's disease of bone	0.000192	0.00139	CcSEcCtD
Doxorubicin—Conjunctivitis—Zoledronate—Paget's disease of bone	0.000192	0.00139	CcSEcCtD
Doxorubicin—Urinary tract disorder—Pamidronate—Paget's disease of bone	0.000192	0.00138	CcSEcCtD
Doxorubicin—Eye disorder—Risedronate—Paget's disease of bone	0.000191	0.00138	CcSEcCtD
Doxorubicin—Connective tissue disorder—Pamidronate—Paget's disease of bone	0.000191	0.00138	CcSEcCtD
Doxorubicin—Paraesthesia—Etidronic acid—Paget's disease of bone	0.000191	0.00138	CcSEcCtD
Doxorubicin—Tinnitus—Risedronate—Paget's disease of bone	0.00019	0.00138	CcSEcCtD
Doxorubicin—Urethral disorder—Pamidronate—Paget's disease of bone	0.00019	0.00137	CcSEcCtD
Doxorubicin—Cardiac disorder—Risedronate—Paget's disease of bone	0.00019	0.00137	CcSEcCtD
Doxorubicin—Chest pain—Alendronate—Paget's disease of bone	0.000189	0.00136	CcSEcCtD
Doxorubicin—Myalgia—Alendronate—Paget's disease of bone	0.000189	0.00136	CcSEcCtD
Doxorubicin—Haematuria—Zoledronate—Paget's disease of bone	0.000188	0.00136	CcSEcCtD
Doxorubicin—NOS3—Myometrial Relaxation and Contraction Pathways—CALCA—Paget's disease of bone	0.000188	0.00724	CbGpPWpGaD
Doxorubicin—Dyspepsia—Etidronic acid—Paget's disease of bone	0.000187	0.00135	CcSEcCtD
Doxorubicin—Discomfort—Alendronate—Paget's disease of bone	0.000186	0.00135	CcSEcCtD
Doxorubicin—Angiopathy—Risedronate—Paget's disease of bone	0.000185	0.00134	CcSEcCtD
Doxorubicin—Immune system disorder—Risedronate—Paget's disease of bone	0.000184	0.00133	CcSEcCtD
Doxorubicin—Agranulocytosis—Zoledronate—Paget's disease of bone	0.000184	0.00133	CcSEcCtD
Doxorubicin—Mediastinal disorder—Risedronate—Paget's disease of bone	0.000184	0.00133	CcSEcCtD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—OPTN—Paget's disease of bone	0.000184	0.00708	CbGpPWpGaD
Doxorubicin—Arrhythmia—Risedronate—Paget's disease of bone	0.000182	0.00132	CcSEcCtD
Doxorubicin—Constipation—Etidronic acid—Paget's disease of bone	0.000181	0.00131	CcSEcCtD
Doxorubicin—Eye disorder—Pamidronate—Paget's disease of bone	0.000181	0.00131	CcSEcCtD
Doxorubicin—Bradycardia—Zoledronate—Paget's disease of bone	0.000181	0.0013	CcSEcCtD
Doxorubicin—Flushing—Pamidronate—Paget's disease of bone	0.00018	0.0013	CcSEcCtD
Doxorubicin—Cardiac disorder—Pamidronate—Paget's disease of bone	0.00018	0.0013	CcSEcCtD
Doxorubicin—Infection—Alendronate—Paget's disease of bone	0.00018	0.0013	CcSEcCtD
Doxorubicin—Mental disorder—Risedronate—Paget's disease of bone	0.000179	0.00129	CcSEcCtD
Doxorubicin—Malnutrition—Risedronate—Paget's disease of bone	0.000178	0.00128	CcSEcCtD
Doxorubicin—Hypoaesthesia—Zoledronate—Paget's disease of bone	0.000176	0.00127	CcSEcCtD
Doxorubicin—Angiopathy—Pamidronate—Paget's disease of bone	0.000176	0.00127	CcSEcCtD
Doxorubicin—Immune system disorder—Pamidronate—Paget's disease of bone	0.000175	0.00127	CcSEcCtD
Doxorubicin—Flatulence—Risedronate—Paget's disease of bone	0.000175	0.00127	CcSEcCtD
Doxorubicin—Urinary tract disorder—Zoledronate—Paget's disease of bone	0.000175	0.00126	CcSEcCtD
Doxorubicin—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.000175	0.00126	CcSEcCtD
Doxorubicin—Feeling abnormal—Etidronic acid—Paget's disease of bone	0.000175	0.00126	CcSEcCtD
Doxorubicin—Oedema peripheral—Zoledronate—Paget's disease of bone	0.000175	0.00126	CcSEcCtD
Doxorubicin—Connective tissue disorder—Zoledronate—Paget's disease of bone	0.000174	0.00126	CcSEcCtD
Doxorubicin—Chills—Pamidronate—Paget's disease of bone	0.000174	0.00126	CcSEcCtD
Doxorubicin—Urethral disorder—Zoledronate—Paget's disease of bone	0.000174	0.00126	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.000174	0.00125	CcSEcCtD
Doxorubicin—AURKA—Cell Cycle, Mitotic—NUP205—Paget's disease of bone	0.000172	0.00664	CbGpPWpGaD
Doxorubicin—Back pain—Risedronate—Paget's disease of bone	0.000172	0.00124	CcSEcCtD
Doxorubicin—DHCR7—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.000172	0.00662	CbGpPWpGaD
Doxorubicin—Alopecia—Pamidronate—Paget's disease of bone	0.000172	0.00124	CcSEcCtD
Doxorubicin—Muscle spasms—Risedronate—Paget's disease of bone	0.000171	0.00123	CcSEcCtD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000171	0.00658	CbGpPWpGaD
Doxorubicin—Malnutrition—Pamidronate—Paget's disease of bone	0.000169	0.00122	CcSEcCtD
Doxorubicin—Erythema—Pamidronate—Paget's disease of bone	0.000169	0.00122	CcSEcCtD
Doxorubicin—Urticaria—Etidronic acid—Paget's disease of bone	0.000169	0.00122	CcSEcCtD
Doxorubicin—Abdominal pain—Etidronic acid—Paget's disease of bone	0.000168	0.00121	CcSEcCtD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000167	0.00642	CbGpPWpGaD
Doxorubicin—Tension—Pamidronate—Paget's disease of bone	0.000166	0.0012	CcSEcCtD
Doxorubicin—Eye disorder—Zoledronate—Paget's disease of bone	0.000166	0.0012	CcSEcCtD
Doxorubicin—Dysgeusia—Pamidronate—Paget's disease of bone	0.000166	0.0012	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.000165	0.00119	CcSEcCtD
Doxorubicin—Flushing—Zoledronate—Paget's disease of bone	0.000165	0.00119	CcSEcCtD
Doxorubicin—Cardiac disorder—Zoledronate—Paget's disease of bone	0.000165	0.00119	CcSEcCtD
Doxorubicin—YWHAG—Cell Cycle—OPTN—Paget's disease of bone	0.000164	0.00633	CbGpPWpGaD
Doxorubicin—Anaemia—Risedronate—Paget's disease of bone	0.000164	0.00119	CcSEcCtD
Doxorubicin—Nervousness—Pamidronate—Paget's disease of bone	0.000164	0.00119	CcSEcCtD
Doxorubicin—Back pain—Pamidronate—Paget's disease of bone	0.000163	0.00118	CcSEcCtD
Doxorubicin—Muscle spasms—Pamidronate—Paget's disease of bone	0.000162	0.00117	CcSEcCtD
Doxorubicin—Angiopathy—Zoledronate—Paget's disease of bone	0.000161	0.00116	CcSEcCtD
Doxorubicin—CBR1—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.00016	0.00618	CbGpPWpGaD
Doxorubicin—Immune system disorder—Zoledronate—Paget's disease of bone	0.00016	0.00116	CcSEcCtD
Doxorubicin—TOP2A—Circadian rythm related genes—PML—Paget's disease of bone	0.00016	0.00617	CbGpPWpGaD
Doxorubicin—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.00016	0.00115	CcSEcCtD
Doxorubicin—Vertigo—Risedronate—Paget's disease of bone	0.00016	0.00115	CcSEcCtD
Doxorubicin—Syncope—Risedronate—Paget's disease of bone	0.000159	0.00115	CcSEcCtD
Doxorubicin—Dyspepsia—Alendronate—Paget's disease of bone	0.000159	0.00115	CcSEcCtD
Doxorubicin—Chills—Zoledronate—Paget's disease of bone	0.000159	0.00115	CcSEcCtD
Doxorubicin—Arrhythmia—Zoledronate—Paget's disease of bone	0.000158	0.00114	CcSEcCtD
Doxorubicin—ABCC3—NRF2 pathway—SQSTM1—Paget's disease of bone	0.000158	0.00609	CbGpPWpGaD
Doxorubicin—Ill-defined disorder—Pamidronate—Paget's disease of bone	0.000157	0.00113	CcSEcCtD
Doxorubicin—Alopecia—Zoledronate—Paget's disease of bone	0.000157	0.00113	CcSEcCtD
Doxorubicin—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.000156	0.00113	CcSEcCtD
Doxorubicin—Loss of consciousness—Risedronate—Paget's disease of bone	0.000156	0.00113	CcSEcCtD
Doxorubicin—Anaemia—Pamidronate—Paget's disease of bone	0.000156	0.00113	CcSEcCtD
Doxorubicin—Mental disorder—Zoledronate—Paget's disease of bone	0.000155	0.00112	CcSEcCtD
Doxorubicin—Agitation—Pamidronate—Paget's disease of bone	0.000155	0.00112	CcSEcCtD
Doxorubicin—Cough—Risedronate—Paget's disease of bone	0.000155	0.00112	CcSEcCtD
Doxorubicin—Pain—Alendronate—Paget's disease of bone	0.000155	0.00112	CcSEcCtD
Doxorubicin—Constipation—Alendronate—Paget's disease of bone	0.000155	0.00112	CcSEcCtD
Doxorubicin—Erythema—Zoledronate—Paget's disease of bone	0.000154	0.00112	CcSEcCtD
Doxorubicin—Malnutrition—Zoledronate—Paget's disease of bone	0.000154	0.00112	CcSEcCtD
Doxorubicin—AURKA—Cell Cycle—NUP205—Paget's disease of bone	0.000154	0.00594	CbGpPWpGaD
Doxorubicin—Hypertension—Risedronate—Paget's disease of bone	0.000154	0.00111	CcSEcCtD
Doxorubicin—Malaise—Pamidronate—Paget's disease of bone	0.000152	0.0011	CcSEcCtD
Doxorubicin—Syncope—Pamidronate—Paget's disease of bone	0.000152	0.00109	CcSEcCtD
Doxorubicin—Myalgia—Risedronate—Paget's disease of bone	0.000151	0.00109	CcSEcCtD
Doxorubicin—Chest pain—Risedronate—Paget's disease of bone	0.000151	0.00109	CcSEcCtD
Doxorubicin—Arthralgia—Risedronate—Paget's disease of bone	0.000151	0.00109	CcSEcCtD
Doxorubicin—Leukopenia—Pamidronate—Paget's disease of bone	0.000151	0.00109	CcSEcCtD
Doxorubicin—Dysgeusia—Zoledronate—Paget's disease of bone	0.000151	0.00109	CcSEcCtD
Doxorubicin—Anxiety—Risedronate—Paget's disease of bone	0.000151	0.00109	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.00015	0.00109	CcSEcCtD
Doxorubicin—Pruritus—Etidronic acid—Paget's disease of bone	0.00015	0.00108	CcSEcCtD
Doxorubicin—Back pain—Zoledronate—Paget's disease of bone	0.000149	0.00108	CcSEcCtD
Doxorubicin—Feeling abnormal—Alendronate—Paget's disease of bone	0.000149	0.00108	CcSEcCtD
Doxorubicin—Loss of consciousness—Pamidronate—Paget's disease of bone	0.000149	0.00107	CcSEcCtD
Doxorubicin—Muscle spasms—Zoledronate—Paget's disease of bone	0.000148	0.00107	CcSEcCtD
Doxorubicin—Dry mouth—Risedronate—Paget's disease of bone	0.000148	0.00107	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.000148	0.00107	CcSEcCtD
Doxorubicin—Cough—Pamidronate—Paget's disease of bone	0.000147	0.00107	CcSEcCtD
Doxorubicin—Convulsion—Pamidronate—Paget's disease of bone	0.000146	0.00106	CcSEcCtD
Doxorubicin—Hypertension—Pamidronate—Paget's disease of bone	0.000146	0.00105	CcSEcCtD
Doxorubicin—Vision blurred—Zoledronate—Paget's disease of bone	0.000145	0.00105	CcSEcCtD
Doxorubicin—Diarrhoea—Etidronic acid—Paget's disease of bone	0.000145	0.00105	CcSEcCtD
Doxorubicin—Infection—Risedronate—Paget's disease of bone	0.000144	0.00104	CcSEcCtD
Doxorubicin—Arthralgia—Pamidronate—Paget's disease of bone	0.000144	0.00104	CcSEcCtD
Doxorubicin—Myalgia—Pamidronate—Paget's disease of bone	0.000144	0.00104	CcSEcCtD
Doxorubicin—Urticaria—Alendronate—Paget's disease of bone	0.000144	0.00104	CcSEcCtD
Doxorubicin—Anxiety—Pamidronate—Paget's disease of bone	0.000143	0.00104	CcSEcCtD
Doxorubicin—Ill-defined disorder—Zoledronate—Paget's disease of bone	0.000143	0.00103	CcSEcCtD
Doxorubicin—NOS1—Hemostasis—INPP5D—Paget's disease of bone	0.000143	0.00551	CbGpPWpGaD
Doxorubicin—Body temperature increased—Alendronate—Paget's disease of bone	0.000143	0.00103	CcSEcCtD
Doxorubicin—Abdominal pain—Alendronate—Paget's disease of bone	0.000143	0.00103	CcSEcCtD
Doxorubicin—Shock—Risedronate—Paget's disease of bone	0.000143	0.00103	CcSEcCtD
Doxorubicin—Anaemia—Zoledronate—Paget's disease of bone	0.000143	0.00103	CcSEcCtD
Doxorubicin—Nervous system disorder—Risedronate—Paget's disease of bone	0.000142	0.00103	CcSEcCtD
Doxorubicin—Discomfort—Pamidronate—Paget's disease of bone	0.000142	0.00103	CcSEcCtD
Doxorubicin—Agitation—Zoledronate—Paget's disease of bone	0.000142	0.00102	CcSEcCtD
Doxorubicin—Skin disorder—Risedronate—Paget's disease of bone	0.000141	0.00102	CcSEcCtD
Doxorubicin—Malaise—Zoledronate—Paget's disease of bone	0.000139	0.00101	CcSEcCtD
Doxorubicin—Confusional state—Pamidronate—Paget's disease of bone	0.000139	0.001	CcSEcCtD
Doxorubicin—Vertigo—Zoledronate—Paget's disease of bone	0.000139	0.001	CcSEcCtD
Doxorubicin—Syncope—Zoledronate—Paget's disease of bone	0.000138	0.001	CcSEcCtD
Doxorubicin—Leukopenia—Zoledronate—Paget's disease of bone	0.000138	0.000998	CcSEcCtD
Doxorubicin—Anaphylactic shock—Pamidronate—Paget's disease of bone	0.000138	0.000996	CcSEcCtD
Doxorubicin—Oedema—Pamidronate—Paget's disease of bone	0.000138	0.000996	CcSEcCtD
Doxorubicin—Infection—Pamidronate—Paget's disease of bone	0.000137	0.00099	CcSEcCtD
Doxorubicin—Palpitations—Zoledronate—Paget's disease of bone	0.000136	0.000985	CcSEcCtD
Doxorubicin—Shock—Pamidronate—Paget's disease of bone	0.000136	0.00098	CcSEcCtD
Doxorubicin—Loss of consciousness—Zoledronate—Paget's disease of bone	0.000136	0.00098	CcSEcCtD
Doxorubicin—Nervous system disorder—Pamidronate—Paget's disease of bone	0.000135	0.000977	CcSEcCtD
Doxorubicin—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.000135	0.000975	CcSEcCtD
Doxorubicin—Vomiting—Etidronic acid—Paget's disease of bone	0.000135	0.000975	CcSEcCtD
Doxorubicin—Cough—Zoledronate—Paget's disease of bone	0.000135	0.000973	CcSEcCtD
Doxorubicin—Tachycardia—Pamidronate—Paget's disease of bone	0.000135	0.000972	CcSEcCtD
Doxorubicin—Rash—Etidronic acid—Paget's disease of bone	0.000134	0.000967	CcSEcCtD
Doxorubicin—Convulsion—Zoledronate—Paget's disease of bone	0.000134	0.000966	CcSEcCtD
Doxorubicin—Dermatitis—Etidronic acid—Paget's disease of bone	0.000134	0.000966	CcSEcCtD
Doxorubicin—Hyperhidrosis—Pamidronate—Paget's disease of bone	0.000133	0.000963	CcSEcCtD
Doxorubicin—Hypertension—Zoledronate—Paget's disease of bone	0.000133	0.000963	CcSEcCtD
Doxorubicin—Hypersensitivity—Alendronate—Paget's disease of bone	0.000133	0.000962	CcSEcCtD
Doxorubicin—Headache—Etidronic acid—Paget's disease of bone	0.000133	0.00096	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.000132	0.000955	CcSEcCtD
Doxorubicin—Anorexia—Pamidronate—Paget's disease of bone	0.000131	0.00095	CcSEcCtD
Doxorubicin—Arthralgia—Zoledronate—Paget's disease of bone	0.000131	0.000949	CcSEcCtD
Doxorubicin—Chest pain—Zoledronate—Paget's disease of bone	0.000131	0.000949	CcSEcCtD
Doxorubicin—Myalgia—Zoledronate—Paget's disease of bone	0.000131	0.000949	CcSEcCtD
Doxorubicin—Insomnia—Risedronate—Paget's disease of bone	0.000131	0.000948	CcSEcCtD
Doxorubicin—Anxiety—Zoledronate—Paget's disease of bone	0.000131	0.000946	CcSEcCtD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—NUP205—Paget's disease of bone	0.000131	0.00503	CbGpPWpGaD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.000131	0.000943	CcSEcCtD
Doxorubicin—Paraesthesia—Risedronate—Paget's disease of bone	0.00013	0.000941	CcSEcCtD
Doxorubicin—Discomfort—Zoledronate—Paget's disease of bone	0.00013	0.000938	CcSEcCtD
Doxorubicin—Asthenia—Alendronate—Paget's disease of bone	0.00013	0.000937	CcSEcCtD
Doxorubicin—Dyspnoea—Risedronate—Paget's disease of bone	0.000129	0.000934	CcSEcCtD
Doxorubicin—Hypotension—Pamidronate—Paget's disease of bone	0.000129	0.000931	CcSEcCtD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—OPTN—Paget's disease of bone	0.000129	0.00495	CbGpPWpGaD
Doxorubicin—Dry mouth—Zoledronate—Paget's disease of bone	0.000129	0.000928	CcSEcCtD
Doxorubicin—Pruritus—Alendronate—Paget's disease of bone	0.000128	0.000924	CcSEcCtD
Doxorubicin—Dyspepsia—Risedronate—Paget's disease of bone	0.000128	0.000923	CcSEcCtD
Doxorubicin—Confusional state—Zoledronate—Paget's disease of bone	0.000127	0.000918	CcSEcCtD
Doxorubicin—Nausea—Etidronic acid—Paget's disease of bone	0.000126	0.000911	CcSEcCtD
Doxorubicin—Oedema—Zoledronate—Paget's disease of bone	0.000126	0.00091	CcSEcCtD
Doxorubicin—Anaphylactic shock—Zoledronate—Paget's disease of bone	0.000126	0.00091	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.000126	0.000908	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.000125	0.000905	CcSEcCtD
Doxorubicin—ABCC2—NRF2 pathway—SQSTM1—Paget's disease of bone	0.000125	0.00482	CbGpPWpGaD
Doxorubicin—Infection—Zoledronate—Paget's disease of bone	0.000125	0.000904	CcSEcCtD
Doxorubicin—Fatigue—Risedronate—Paget's disease of bone	0.000125	0.000904	CcSEcCtD
Doxorubicin—Insomnia—Pamidronate—Paget's disease of bone	0.000125	0.000901	CcSEcCtD
Doxorubicin—Pain—Risedronate—Paget's disease of bone	0.000124	0.000896	CcSEcCtD
Doxorubicin—Constipation—Risedronate—Paget's disease of bone	0.000124	0.000896	CcSEcCtD
Doxorubicin—Shock—Zoledronate—Paget's disease of bone	0.000124	0.000895	CcSEcCtD
Doxorubicin—Paraesthesia—Pamidronate—Paget's disease of bone	0.000124	0.000895	CcSEcCtD
Doxorubicin—Diarrhoea—Alendronate—Paget's disease of bone	0.000124	0.000894	CcSEcCtD
Doxorubicin—Nervous system disorder—Zoledronate—Paget's disease of bone	0.000124	0.000892	CcSEcCtD
Doxorubicin—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.000123	0.000891	CcSEcCtD
Doxorubicin—Dyspnoea—Pamidronate—Paget's disease of bone	0.000123	0.000888	CcSEcCtD
Doxorubicin—Tachycardia—Zoledronate—Paget's disease of bone	0.000123	0.000888	CcSEcCtD
Doxorubicin—Somnolence—Pamidronate—Paget's disease of bone	0.000123	0.000886	CcSEcCtD
Doxorubicin—Skin disorder—Zoledronate—Paget's disease of bone	0.000122	0.000884	CcSEcCtD
Doxorubicin—Hyperhidrosis—Zoledronate—Paget's disease of bone	0.000122	0.00088	CcSEcCtD
Doxorubicin—Dyspepsia—Pamidronate—Paget's disease of bone	0.000121	0.000877	CcSEcCtD
Doxorubicin—Anorexia—Zoledronate—Paget's disease of bone	0.00012	0.000867	CcSEcCtD
Doxorubicin—Decreased appetite—Pamidronate—Paget's disease of bone	0.00012	0.000866	CcSEcCtD
Doxorubicin—Dizziness—Alendronate—Paget's disease of bone	0.00012	0.000864	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.000119	0.00086	CcSEcCtD
Doxorubicin—Fatigue—Pamidronate—Paget's disease of bone	0.000119	0.000859	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.000119	0.000857	CcSEcCtD
Doxorubicin—Pain—Pamidronate—Paget's disease of bone	0.000118	0.000852	CcSEcCtD
Doxorubicin—Constipation—Pamidronate—Paget's disease of bone	0.000118	0.000852	CcSEcCtD
Doxorubicin—Hypotension—Zoledronate—Paget's disease of bone	0.000118	0.00085	CcSEcCtD
Doxorubicin—YWHAG—Cell Cycle—NUP205—Paget's disease of bone	0.000117	0.0045	CbGpPWpGaD
Doxorubicin—Urticaria—Risedronate—Paget's disease of bone	0.000115	0.000833	CcSEcCtD
Doxorubicin—Vomiting—Alendronate—Paget's disease of bone	0.000115	0.00083	CcSEcCtD
Doxorubicin—TOP2A—Cell Cycle—OPTN—Paget's disease of bone	0.000115	0.00443	CbGpPWpGaD
Doxorubicin—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.000115	0.000829	CcSEcCtD
Doxorubicin—Body temperature increased—Risedronate—Paget's disease of bone	0.000115	0.000828	CcSEcCtD
Doxorubicin—Abdominal pain—Risedronate—Paget's disease of bone	0.000115	0.000828	CcSEcCtD
Doxorubicin—Rash—Alendronate—Paget's disease of bone	0.000114	0.000824	CcSEcCtD
Doxorubicin—Insomnia—Zoledronate—Paget's disease of bone	0.000114	0.000823	CcSEcCtD
Doxorubicin—Dermatitis—Alendronate—Paget's disease of bone	0.000114	0.000823	CcSEcCtD
Doxorubicin—Feeling abnormal—Pamidronate—Paget's disease of bone	0.000114	0.000821	CcSEcCtD
Doxorubicin—Headache—Alendronate—Paget's disease of bone	0.000113	0.000818	CcSEcCtD
Doxorubicin—Paraesthesia—Zoledronate—Paget's disease of bone	0.000113	0.000817	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.000113	0.000815	CcSEcCtD
Doxorubicin—NDUFS7—Metabolism—NUP205—Paget's disease of bone	0.000112	0.00433	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—NUP205—Paget's disease of bone	0.000112	0.00433	CbGpPWpGaD
Doxorubicin—Dyspnoea—Zoledronate—Paget's disease of bone	0.000112	0.000811	CcSEcCtD
Doxorubicin—Somnolence—Zoledronate—Paget's disease of bone	0.000112	0.000809	CcSEcCtD
Doxorubicin—Dyspepsia—Zoledronate—Paget's disease of bone	0.000111	0.000801	CcSEcCtD
Doxorubicin—Decreased appetite—Zoledronate—Paget's disease of bone	0.00011	0.000791	CcSEcCtD
Doxorubicin—Abdominal pain—Pamidronate—Paget's disease of bone	0.000109	0.000788	CcSEcCtD
Doxorubicin—Body temperature increased—Pamidronate—Paget's disease of bone	0.000109	0.000788	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.000109	0.000786	CcSEcCtD
Doxorubicin—Fatigue—Zoledronate—Paget's disease of bone	0.000109	0.000785	CcSEcCtD
Doxorubicin—NOS2—Hemostasis—INPP5D—Paget's disease of bone	0.000108	0.00416	CbGpPWpGaD
Doxorubicin—Constipation—Zoledronate—Paget's disease of bone	0.000108	0.000778	CcSEcCtD
Doxorubicin—Pain—Zoledronate—Paget's disease of bone	0.000108	0.000778	CcSEcCtD
Doxorubicin—Nausea—Alendronate—Paget's disease of bone	0.000107	0.000776	CcSEcCtD
Doxorubicin—Hypersensitivity—Risedronate—Paget's disease of bone	0.000107	0.000772	CcSEcCtD
Doxorubicin—NOS1—Disease—VCP—Paget's disease of bone	0.000106	0.0041	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—NUP205—Paget's disease of bone	0.000106	0.00407	CbGpPWpGaD
Doxorubicin—Asthenia—Risedronate—Paget's disease of bone	0.000104	0.000752	CcSEcCtD
Doxorubicin—Feeling abnormal—Zoledronate—Paget's disease of bone	0.000104	0.00075	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.000103	0.000744	CcSEcCtD
Doxorubicin—Pruritus—Risedronate—Paget's disease of bone	0.000103	0.000741	CcSEcCtD
Doxorubicin—Hypersensitivity—Pamidronate—Paget's disease of bone	0.000102	0.000734	CcSEcCtD
Doxorubicin—Urticaria—Zoledronate—Paget's disease of bone	0.0001	0.000723	CcSEcCtD
Doxorubicin—Abdominal pain—Zoledronate—Paget's disease of bone	9.96e-05	0.000719	CcSEcCtD
Doxorubicin—Body temperature increased—Zoledronate—Paget's disease of bone	9.96e-05	0.000719	CcSEcCtD
Doxorubicin—Diarrhoea—Risedronate—Paget's disease of bone	9.93e-05	0.000717	CcSEcCtD
Doxorubicin—Asthenia—Pamidronate—Paget's disease of bone	9.9e-05	0.000715	CcSEcCtD
Doxorubicin—Pruritus—Pamidronate—Paget's disease of bone	9.76e-05	0.000705	CcSEcCtD
Doxorubicin—Dizziness—Risedronate—Paget's disease of bone	9.6e-05	0.000693	CcSEcCtD
Doxorubicin—NDUFS7—Metabolism—INPP5D—Paget's disease of bone	9.58e-05	0.00369	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—INPP5D—Paget's disease of bone	9.58e-05	0.00369	CbGpPWpGaD
Doxorubicin—Diarrhoea—Pamidronate—Paget's disease of bone	9.44e-05	0.000682	CcSEcCtD
Doxorubicin—RALBP1—Signaling Pathways—VCP—Paget's disease of bone	9.32e-05	0.00359	CbGpPWpGaD
Doxorubicin—Hypersensitivity—Zoledronate—Paget's disease of bone	9.28e-05	0.00067	CcSEcCtD
Doxorubicin—Vomiting—Risedronate—Paget's disease of bone	9.23e-05	0.000666	CcSEcCtD
Doxorubicin—Rash—Risedronate—Paget's disease of bone	9.15e-05	0.000661	CcSEcCtD
Doxorubicin—Dermatitis—Risedronate—Paget's disease of bone	9.14e-05	0.00066	CcSEcCtD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—NUP205—Paget's disease of bone	9.14e-05	0.00352	CbGpPWpGaD
Doxorubicin—Dizziness—Pamidronate—Paget's disease of bone	9.12e-05	0.000659	CcSEcCtD
Doxorubicin—Headache—Risedronate—Paget's disease of bone	9.09e-05	0.000657	CcSEcCtD
Doxorubicin—Asthenia—Zoledronate—Paget's disease of bone	9.04e-05	0.000653	CcSEcCtD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	9.03e-05	0.00348	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—INPP5D—Paget's disease of bone	9.01e-05	0.00347	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—NUP205—Paget's disease of bone	8.98e-05	0.00346	CbGpPWpGaD
Doxorubicin—Pruritus—Zoledronate—Paget's disease of bone	8.91e-05	0.000644	CcSEcCtD
Doxorubicin—Vomiting—Pamidronate—Paget's disease of bone	8.77e-05	0.000633	CcSEcCtD
Doxorubicin—Rash—Pamidronate—Paget's disease of bone	8.7e-05	0.000628	CcSEcCtD
Doxorubicin—Dermatitis—Pamidronate—Paget's disease of bone	8.69e-05	0.000628	CcSEcCtD
Doxorubicin—Headache—Pamidronate—Paget's disease of bone	8.64e-05	0.000624	CcSEcCtD
Doxorubicin—Diarrhoea—Zoledronate—Paget's disease of bone	8.62e-05	0.000623	CcSEcCtD
Doxorubicin—Nausea—Risedronate—Paget's disease of bone	8.62e-05	0.000623	CcSEcCtD
Doxorubicin—NOS3—Hemostasis—INPP5D—Paget's disease of bone	8.38e-05	0.00323	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—NUP205—Paget's disease of bone	8.38e-05	0.00323	CbGpPWpGaD
Doxorubicin—Dizziness—Zoledronate—Paget's disease of bone	8.33e-05	0.000602	CcSEcCtD
Doxorubicin—Nausea—Pamidronate—Paget's disease of bone	8.19e-05	0.000592	CcSEcCtD
Doxorubicin—TOP2A—Cell Cycle—NUP205—Paget's disease of bone	8.17e-05	0.00315	CbGpPWpGaD
Doxorubicin—NOS1—Disease—NUP205—Paget's disease of bone	8.13e-05	0.00313	CbGpPWpGaD
Doxorubicin—NOS2—Disease—VCP—Paget's disease of bone	8.02e-05	0.00309	CbGpPWpGaD
Doxorubicin—Vomiting—Zoledronate—Paget's disease of bone	8.01e-05	0.000579	CcSEcCtD
Doxorubicin—Rash—Zoledronate—Paget's disease of bone	7.94e-05	0.000574	CcSEcCtD
Doxorubicin—Dermatitis—Zoledronate—Paget's disease of bone	7.94e-05	0.000573	CcSEcCtD
Doxorubicin—Headache—Zoledronate—Paget's disease of bone	7.89e-05	0.00057	CcSEcCtD
Doxorubicin—DHCR7—Metabolism—INPP5D—Paget's disease of bone	7.66e-05	0.00295	CbGpPWpGaD
Doxorubicin—Nausea—Zoledronate—Paget's disease of bone	7.48e-05	0.000541	CcSEcCtD
Doxorubicin—AKR1C3—Disease—VCP—Paget's disease of bone	7.37e-05	0.00284	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—INPP5D—Paget's disease of bone	7.14e-05	0.00275	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	6.62e-05	0.00255	CbGpPWpGaD
Doxorubicin—NOS3—Disease—VCP—Paget's disease of bone	6.23e-05	0.0024	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	6.19e-05	0.00238	CbGpPWpGaD
Doxorubicin—NOS2—Disease—NUP205—Paget's disease of bone	6.13e-05	0.00236	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CALCA—Paget's disease of bone	6.03e-05	0.00232	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	5.94e-05	0.00229	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—NUP205—Paget's disease of bone	5.63e-05	0.00217	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	5.49e-05	0.00212	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—SQSTM1—Paget's disease of bone	5.44e-05	0.0021	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CALCA—Paget's disease of bone	5.29e-05	0.00204	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	5.25e-05	0.00202	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	5.19e-05	0.002	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—VCP—Paget's disease of bone	5.16e-05	0.00199	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—NUP205—Paget's disease of bone	4.89e-05	0.00188	CbGpPWpGaD
Doxorubicin—NOS3—Disease—NUP205—Paget's disease of bone	4.76e-05	0.00183	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—NUP205—Paget's disease of bone	4.72e-05	0.00182	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	4.65e-05	0.00179	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	4.56e-05	0.00176	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CALCA—Paget's disease of bone	4.55e-05	0.00175	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	4.5e-05	0.00173	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—NUP205—Paget's disease of bone	4.39e-05	0.00169	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—VCP—Paget's disease of bone	4.36e-05	0.00168	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CALCA—Paget's disease of bone	4.18e-05	0.00161	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—INPP5D—Paget's disease of bone	4.17e-05	0.00161	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—INPP5D—Paget's disease of bone	4.02e-05	0.00155	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—NUP205—Paget's disease of bone	3.99e-05	0.00154	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—VCP—Paget's disease of bone	3.8e-05	0.00146	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—INPP5D—Paget's disease of bone	3.74e-05	0.00144	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CALCA—Paget's disease of bone	3.53e-05	0.00136	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—INPP5D—Paget's disease of bone	3.4e-05	0.00131	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—NUP205—Paget's disease of bone	3.23e-05	0.00125	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—NUP205—Paget's disease of bone	3.1e-05	0.00119	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SQSTM1—Paget's disease of bone	3.02e-05	0.00116	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CALCA—Paget's disease of bone	2.93e-05	0.00113	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NUP205—Paget's disease of bone	2.9e-05	0.00112	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—INPP5D—Paget's disease of bone	2.76e-05	0.00106	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—INPP5D—Paget's disease of bone	2.64e-05	0.00102	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SQSTM1—Paget's disease of bone	2.55e-05	0.000981	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CALCA—Paget's disease of bone	2.47e-05	0.000953	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	2.47e-05	0.00095	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—NUP205—Paget's disease of bone	2.43e-05	0.000936	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—NUP205—Paget's disease of bone	2.35e-05	0.000905	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CALCA—Paget's disease of bone	2.15e-05	0.000829	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—NUP205—Paget's disease of bone	2.14e-05	0.000823	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—INPP5D—Paget's disease of bone	2.07e-05	0.000798	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—INPP5D—Paget's disease of bone	2e-05	0.000772	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—INPP5D—Paget's disease of bone	1.82e-05	0.000702	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—NUP205—Paget's disease of bone	1.57e-05	0.000604	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—INPP5D—Paget's disease of bone	1.34e-05	0.000515	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NUP205—Paget's disease of bone	1.16e-05	0.000445	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NUP205—Paget's disease of bone	1.09e-05	0.000419	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—INPP5D—Paget's disease of bone	9.86e-06	0.00038	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—INPP5D—Paget's disease of bone	9.29e-06	0.000358	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NUP205—Paget's disease of bone	7.12e-06	0.000274	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—INPP5D—Paget's disease of bone	6.07e-06	0.000234	CbGpPWpGaD
